Literature DB >> 17017003

Toward an evidence-based toxicology.

S Hoffmann1, T Hartung.   

Abstract

The increasing demands on toxicology of large-scale risk assessment programmes for chemicals and emerging or expanding areas of chemical use suggest it is timely to review the toxicological toolbox. Like in clinical medicine, where an evidence-based medicine (EBM) is critically reviewing traditional approaches, toxicology has the opportunity to reshape and enlarge its methodology and approaches on the basis of compounded scientific knowledge. Such revision would have to be based on structured reviews of current practice, ie, assessment of test performance characteristics, mechanistic understanding, extended quality assurance, formal validation and the use of integrated testing strategies. This form of revision could optimize the balance between safety, costs and animal welfare, explicitly stating and, where possible, quantifying uncertainties. After a self-critical reassessment of current practices and evaluation of the thus generated information, such an evidence-based toxicology (EBT) promises to make better use of resources and to increase the quality of results, facilitating their interpretation. It shall open up hazard and also risk assessments to new technologies, flexibly accommodating current and future mechanistic understanding. An EBT will be better prepared to answer the continuously growing safety demands of modern societies.

Mesh:

Year:  2006        PMID: 17017003     DOI: 10.1191/0960327106het648oa

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  27 in total

Review 1.  Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.

Authors:  Lena Smirnova; Helena T Hogberg; Marcel Leist; Thomas Hartung
Journal:  ALTEX       Date:  2014       Impact factor: 6.043

2.  The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.

Authors:  Michael Balls; Patric Amcoff; Susanne Bremer; Silvia Casati; Sandra Coecke; Richard Clothier; Robert Combes; Raffaella Corvi; Rodger Curren; Chantra Eskes; Julia Fentem; Laura Gribaldo; Marlies Halder; Thomas Hartung; Sebastian Hoffmann; Leonard Schectman; Laurie Scott; Horst Spielmann; William Stokes; Raymond Tice; Drew Wagner; Valérie Zuang
Journal:  Altern Lab Anim       Date:  2006-12       Impact factor: 1.303

3.  Toxicology for the twenty-first century.

Authors:  Thomas Hartung
Journal:  Nature       Date:  2009-07-09       Impact factor: 49.962

4.  Integrated testing strategies for safety assessments.

Authors:  Thomas Hartung; Tom Luechtefeld; Alexandra Maertens; Andre Kleensang
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

5.  Look back in anger - what clinical studies tell us about preclinical work.

Authors:  Thomas Hartung
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

Review 6.  Biological and medical applications of a brain-on-a-chip.

Authors:  David Pamies; Thomas Hartung; Helena T Hogberg
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-09

7.  Mechanistic validation.

Authors:  Thomas Hartung; Sebastian Hoffmann; Martin Stephens
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

Review 8.  Perspectives on In Vitro to In Vivo Extrapolations.

Authors:  Thomas Hartung
Journal:  Appl In Vitro Toxicol       Date:  2018-12-08

9.  Implementing systematic review techniques in chemical risk assessment: Challenges, opportunities and recommendations.

Authors:  Paul Whaley; Crispin Halsall; Marlene Ågerstrand; Elisa Aiassa; Diane Benford; Gary Bilotta; David Coggon; Chris Collins; Ciara Dempsey; Raquel Duarte-Davidson; Rex FitzGerald; Malyka Galay-Burgos; David Gee; Sebastian Hoffmann; Juleen Lam; Toby Lasserson; Len Levy; Steven Lipworth; Sarah Mackenzie Ross; Olwenn Martin; Catherine Meads; Monika Meyer-Baron; James Miller; Camilla Pease; Andrew Rooney; Alison Sapiets; Gavin Stewart; David Taylor
Journal:  Environ Int       Date:  2015-12-11       Impact factor: 9.621

10.  Moving forward in human cancer risk assessment.

Authors:  Richard S Paules; Jiri Aubrecht; Raffaella Corvi; Bernward Garthoff; Jos C Kleinjans
Journal:  Environ Health Perspect       Date:  2010-12-13       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.